VRTX SEC filings last scanned 22 Aug 2026, 16:41 UTC
CEO Timeline
Dr. Reshma KewalramaniCurrent
Apr 2020 — Present(6y 5mo)
Dr. Reshma Kewalramani was appointed President and Chief Executive Officer of Vertex Pharmaceuticals Incorporated, effective April 1, 2020.
1 source filing — click to expand
Jeffrey M. Leiden
Feb 2012 — Apr 2020(8y 2mo)
Dr. Jeffrey M. Leiden was appointed President and Chief Executive Officer of Vertex Pharmaceuticals, effective February 1, 2012, succeeding Matthew W. Emmens.
transitioned to Executive Chairman role
4 source filings — click to expand
Matthew Emmens
May 2009 — Feb 2012(2y 9mo)
Matthew Emmens was appointed Chief Executive Officer and Chairman of Vertex Pharmaceuticals, effective May 23, 2009, succeeding Joshua S. Boger.
planned transition to Executive Chairman, with planned retirement on May 22, 2012